Stocktoria
CITIUS ONCOLOGY, INC. CTOR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2022-10-14
CITIUS ONCOLOGY, INC. statistics & valuation
Market cap$57.6M
P / B1.3×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Return on assets | -24.5% | -25.1% | 3.3% | -26.6% | 0.6% |
| Return on equity | -55.2% | -45.8% | 10.6% | -49.7% | 110.2% |
| Current ratio | 0.56 | 0.34 | 0.03 | 0.37 | 11.85 |
Source: SEC EDGAR filings · CIK 0001851484 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.